VRDN |
Viridian Therapeutics, Inc.\DE |
Sep 27, 2024 |
1 |
$499K |
4 |
Sep 30, 2024 |
President and CEO, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Oct 30, 2023 |
1 |
$0 |
4 |
Nov 1, 2023 |
President and CEO, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Oct 30, 2023 |
0 |
$0 |
3 |
Nov 1, 2023 |
President and CEO, Director |
MGTA |
Magenta Therapeutics, Inc. |
Nov 30, 2022 |
1 |
$2.82K |
4 |
Dec 2, 2022 |
Title: Chief Financial and Operating Officer |
MGTA |
Magenta Therapeutics, Inc. |
Aug 1, 2022 |
1 |
$0 |
4 |
Aug 1, 2022 |
Title: Chief Financial and Operating Officer Exhibit 24.1: Power of Attorney |
MGTA |
Magenta Therapeutics, Inc. |
May 17, 2022 |
1 |
$0 |
4 |
May 19, 2022 |
Title: Chief Financial and Operating Officer |
MGTA |
Magenta Therapeutics, Inc. |
Feb 15, 2022 |
1 |
$0 |
4 |
Feb 17, 2022 |
Title: Chief Financial and Operating Officer |
MGTA |
Magenta Therapeutics, Inc. |
Sep 16, 2021 |
1 |
-$38.6K |
4 |
Sep 20, 2021 |
Chief Financial and Operating Officer |
MGTA |
Magenta Therapeutics, Inc. |
Sep 14, 2021 |
1 |
$0 |
4 |
Sep 16, 2021 |
Chief Financial and Operating Officer |